Tlc Biopharmaceuticals, Inc.
Clinical trials sponsored by Tlc Biopharmaceuticals, Inc., explained in plain language.
-
Could a single shot after surgery cut pain and opioid use?
Symptom relief Recruiting nowThis study is testing a new, long-acting local anesthetic called TLC590 for pain relief after bunion surgery. The goal is to see if a single injection at the surgical site can provide better pain control and reduce the need for opioid painkillers compared to standard treatments a…
Phase: PHASE3 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
New drug aims to block surgery pain for days
Symptom relief Recruiting nowThis study is testing a new, long-acting pain medication called TLC590 in people having common surgeries like knee replacements, tummy tucks, and breast augmentations. Researchers want to find the safest and most effective dose and see how the body processes the drug compared to …
Phase: PHASE2 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC